However, the role of IL-6 on ICIs treatment for gastric adenocarcinoma (GAC) and esophageal squamous cell carcinoma (ESCC) — two of the most prevalent and aggressive upper gastrointestinal malignancies — remains unclear. This evidence concerns the gene IL6 and gastric adenocarcinoma.